Information Portal
Your trusted source for understanding and managing chronic lung diseases.
Taking control of your lung health starts with the right information.
Do you, or someone you know, suffer from a chronic lung disease? Are you a healthcare professional working in this field?
This information portal has been designed to provide reliable information on common chronic lung diseases.
Choose one of the following categories to get started:
Explore our education platform designed for healthcare professionals:
What's New in Chronic Lung Diseases:
Unlock COPD Insights:
November Awareness Campaign
Join us in recognizing COPD Awareness Month this November. Explore a wealth of educational content, access free resources, and benefit from exclusive course discounts designed for healthcare and exercise professionals.
Season 4 of The Expand Podcast is finally here!
Join us as we dive into the world of COVID-19 while unlocking the secrets not just of respiratory health, but other diseases as well.
We have prepared 6 episodes to study this condition from different perspectives, such as hypertension, immunosuppression, endocrinology, primary care, long COVID, and more.
Join our mailing list
Get the latest updates on Chronic Lung Diseases
Whether you’re a patient or healthcare professional, our regular updates will keep you informed on the latest research, treatments, and news.
By subscribing, I hereby agree and consent to the Terms of Use and the Privacy Policy and accept to be contacted via email by Respiplus.You can unsubscribe from the mailing list or change your preferences at any point.
Cognitive and Mood Changes on Lorlatinib
CNS effects on lorlatinib are usually early, Grade 1–2, and reversible. The real risk is delayed recognition. How to interrupt rapidly and re-initiate safely.
Peripheral Neuropathy on Lorlatinib
Neuropathy on lorlatinib often begins subtly and can persist if ignored. How to recognise the pattern, assess functional impact, and keep patients on therapy safely.
Peripheral Edema on Lorlatinib
Peripheral edema is common on lorlatinib. How to distinguish benign swelling from functionally limiting cases, and manage it stepwise without interrupting therapy.
Managing Weight Gain on Lorlatinib in ALK+ NSCLC
Weight gain occurred in approximately 44% of patients on lorlatinib in long-term CROWN follow-up. How to recognise the pattern early and counsel patients realistically.
The PMMR Framework for Lorlatinib Adverse Events
Prepare, Monitor, Manage, Reassess: a practical framework for keeping patients with ALK-positive NSCLC on lorlatinib. Presented by Dr. Geoffrey Liu.
Biologics for COPD: A Practical Guide for Clinicians
Dr. Stephanie Christenson discusses COPD biologics, eosinophil biomarkers and trial evidence in Season 8 of The eXpand Podcast.
COPD Enters the Biologic Era: Are Your Patients Ready?
Explore how biologic therapies are transforming COPD care. Dr. MeiLan Han breaks down biomarkers, clinical trials, and patient selection in Season 8 of the eXpand Podcast.
Preventing Respiratory Infections in Indigenous Communities
Practical strategies to prevent respiratory infections in Indigenous and remote communities, including early intervention and community engagement.
Early Treatment for COVID-19 in Remote Communities
Learn why early testing and antiviral treatment are critical for respiratory infections in remote and Indigenous communities.
Vaccination Strategies in Indigenous Communities
Explore vaccination strategies for COVID-19 and respiratory illnesses in Indigenous communities, including trust-building and culturally safe care.